nevirapine and nelfinavir

nevirapine has been researched along with nelfinavir in 88 studies

Research

Studies (88)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (20.45)18.2507
2000's58 (65.91)29.6817
2010's11 (12.50)24.3611
2020's1 (1.14)2.80

Authors

AuthorsStudies
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Max, B; Mourikes, N1
Back, DJ; Barry, MG; Breckenridge, AM; Halifax, KL; Merry, C; Mulcahy, F; Ryan, M; Tjia, JF1
Anderson, R; Beebe, S; Dusek, A; Grosso, R; Kerr, B; Leoung, G; Skowron, G1
Saag, MS; Schooley, RT1
Brew, BJ; Markus, R1
Back, D; Barry, M; Merry, C; Mulcahy, F1
Acosta, EP; Fletcher, CV; Kakuda, TN1
Baba, M; Okamoto, M; Okamoto, T1
Efron, B; Lawrence, J; Merigan, TC; Montoya, J; Pesano, R; Schapiro, J; Winslow, D; Winters, M; Zolopa, A1
Becker, M; Chesney, M; Deeks, SG; Grant, RM; Hellmann, NS; Parkin, NT; Petropoulos, CJ; Symonds, W; Volberding, PA1
Brooks, D; DiMassimo, E; Dusek, A; Eron, JJ; Gleavy, J; Hopkins, S; Ngo, L; Pilcher, CD; Sista, P; Venetta, T1
Temesgen, Z; Wright, AJ1
Adamson, CS; Binley, JM; Hurley, A; Jones, IM; Krausslich, HG; Markowitz, M; Moore, JP; Roux, KH; Schiller, DS1
Bernasconi, E; Carota, A; Magenta, L; Moccetti, T; Piffaretti, JC1
Skowron, G1
Butler, KM; Clarke, SM; Condon, S; Healy, CM; Mulcahy, F1
Back, D; Drake, S; Halifax, K; Little, J; Taylor, S1
Allende, MC; Belloso, WH; Benetucci, JA; Cahn, PE; Davey, RT; Emery, S; Lane, HC; Lasala, MC; Law, MG; Lopardo, G; Losso, MH; Nelson, E; Salomon, H; Saracco, M1
Abrams, E; Aguayo, R; Bamji, M; Dieudonne, A; Jackson, JB; Johnson, G; Kovacs, A; Krogstad, P; Lee, S; McNamara, J; Mendez, H; Moye, J; Nachman, S; Rana, S; Sever, J; Stanley, K; Wiznia, A1
Antela, A; Casado, JL; Dehertogh, P; Dronda, F; Hertogs, K; Martí-Belda, P; Moreno, S; Sabido, R1
Moore, T; Ware, AJ1
Cunningham, S; Eshleman, SH; Jackson, JB; Johnson, G; Krogstad, P; Lee, S; Nachman, S; Palumbo, P; Wang, YG; Wantman, M; Wei, LJ; Wiznia, A1
Chiodo, F; Manfredi, R1
Black, FT; Jensen-Fangel, S; Larsen, L; Obel, N; Thomsen, HF1
Bartoli, A; Feroggio, M; Gianelli, L; Maserati, R; Montagna, M; Regazzi, MB; Villani, P1
Bourin, M; Dailly, E; Jolliet, P; Kergueris, MF; Thomas, L1
Burger, DM; Chesney, MA; Danner, SA; de Wolf, F; Hoetelmans, RM; Hugen, PW; Jambroes, M; Kauffmann, RH; Lange, JM; Meenhorst, PL; Nieuwkerk, PT; Schneider, MM; Schrey, G; Sprangers, MA; Sprenger, HG; van Der Ende, ME1
Bower, M; Gazzard, BG; Johnson, MA; Lampe, F; Mandalia, S; Matthews, GV; Nelson, MR; Phillips, AN; Sabin, CA1
Aguayo, R; Dieudonne, A; Jackson, JB; Johnson, G; Khoury, M; Krogstad, P; Lee, S; McNamara, J; Mendez, H; Moye, J; Nachman, S; Stanley, K; Wiznia, A1
de Groot, R; Fraaij, PL; van Rossum, AM1
Johnson, GM; Krogstad, PA; Lee, S; Mohan, K; Morse, EV; Nachman, S; Stanley, K; Van Dyke, RB; Wiznia, A1
Edno-Mcheik, L; Lagrange, F; Molimard, M; Moore, N; Péhourcq, F; Titier, K1
Aranda, M; Badía, X; Barrufet, P; Cahn, P; Casado, A; Casiró, A; Consiglio, E; Estela, J; Ferrer, E; Gatell, JM; González, A; Llibre, JM; Lozano, L; Luna, E; Lupo, S; Maños, M; Martínez-Lacasa, J; Miró, JM; Ocaña, I; Pedrol, E; Perez, JL; Perez, P; Podzamczer, D1
Arnedo, M; Barberá, MJ; Ferrer, E; Fumero, E; Gatell, JM; Gudiol, F; McKenna, P; Pérez, JL; Podzamczer, D; Pumarola, T; Rinehart, A1
Burger, DM; Droste, JA; Verweij-Van Wissen, CP1
Aweeka, FT; Floren, LC; Hayashi, S; Jayewardene, A; Johnson, G; Krogstad, P; Nachman, S; Stanley, K; Wiznia, A1
Gerstoft, J; Katzenstein, TL; Kirk, O; Lundgren, JD; Mathiesen, L; Nielsen, H; Obel, N; Pedersen, C1
Barbera, MJ; Ferrer, E; Fisac, C; Fumero, E; Podzamczer, D; Vilarasau, C; Virgili, N1
Gerstoft, J; Katzenstein, TL; Kirk, O; Lundgren, JD; Mathiesen, LR; Nielsen, H; Obel, N; Pedersen, C1
Cardellach, F; Casademont, J; García-Viejo, MA; Gatell, JM; López, S; Martínez, E; Milinkovic, A; Miró, O; Nunes, V; Pedrol, E; Rodríguez-Santiago, B; Soler, A1
Fisher, A; Grosso, R; Hall, DB; Jacobs, M; Kerr, B; Leoung, G; Lewis, R; MacGregor, T; Odgen, R; Robinson, P; Skowron, G; Stevens, M; Yen-Lieberman, B1
Barberá, MJ; Barceló, JJ; Ferrer, E; Gallart, T; García, A; García, F; Gatell, JM; Lacarcel, M; Maleno, MJ; Martínez, C; Miró, JM; Plana, M; Podzamczer, D1
Baker, D; Foca, M; Frenkel, LM; Gandia, J; Gonzalez-Garcia, A; Hitti, J; Huang, S; McNamara, J; Nachman, SA; Paul, ME; Provisor, A; Stek, AM; Stevens, LM; Thorpe, EM; Watts, DH; Wei, LJ1
Chiesi, A; Fisher, M; Horban, A; Kirk, O; Ledergerber, B; Lundgren, JD; Machala, L; Mulchany, F; Phillips, AN; Reiss, P1
Beckerman, K; Chavers, S; Covington, DL; Dominguez, K; Garcia, P; Ross, B; Sacks, S; Scheuerle, A; Tilson, H; Watts, DH1
Boer, K; Dieleman, JP; Godfried, MH; Tempelman, C; Timmermans, S; van der Ende, ME1
Gerber, JG; Wyles, DL1
Jaillon, P; Poirier, JM; Robidou, P1
Boer, K; de Wolf, F; Dieleman, J; Godfried, MH; Nellen, J; Schneider, ME; Sprenger, H; Tempelman, C; Timmermans, S; van der Ende, ME1
Qazi, S; Uckun, FM; Venkatachalam, TK1
Burger, DM; Droste, JA; Hekster, YA; Koopmans, PP1
Acosta, EP; Aldrovandi, G; Chen, J; Damle, B; Hodge, J; Hughes, MD; King, JR; Nachman, S; Wiznia, A; Yogev, R1
Brown, CR; Hong-Brown, LQ; Lang, CH1
Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC1
Aymard, G; Bergmann, JF; Mahé, I; Mouly, S; Rizzo-Padoin, N; Salvat, C; Simoneau, G; Verstuyft, C1
Balfour, HH; Brundage, RC; Vezina, HE; Weller, DR1
Clax, PA; Cohn, SE; Hitti, J; Lertora, JJ; Park, JG; Stek, A; Watts, DH; Yu, S1
Choi, SO; Kashuba, AD; Rezk, NL1
Anastos, K; Cohen, M; Cole, S; Hessol, NA; Justman, J; Kaplan, RC; Lu, D; Shi, Q; Tien, PC; Vigen, C; Young, M1
Asboe, D; Babiker, AG; Darbyshire, JH; Goodall, RL; Hooker, MH; Williams, IG1
Bavoux, F; Benhayoun, M; Brasme, JF; Dauger, S; Faye, A; Lachassinne, E; Mille, F; Teissier, N1
Antinori, A; Baxter, J; Cauda, R; Clevenbergh, P; Colafigli, M; De Luca, A; Giambenedetto, SD; Perno, CF; Prosperi, M; Ruiz, L; Trotta, MP1
Clax, PA; Cohn, SE; Hitti, J; Lertora, JJ; Muderspach, L; Park, JG; Stek, A; Watts, DH; Yu, S1
Doerries, R; Drechsler, H; Gass, A; Hardmeier, M; Kuhle, J; Mehling, M; Ruegg, S1
Fulco, PP; Higginson, RT; Zingone, MM1
Amici, R; Baroncelli, S; Cusato, M; Floridia, M; Galluzzo, CM; Molinari, A; Pinnetti, C; Pirillo, MF; Regazzi, M; Sabbatini, F; Tamburrini, E; Villani, P1
Boesmans, D; Di Fazio, V; Elens, L; Haufroid, V; Vanbinst, R; Veriter, S; Wallemacq, P1
Cheng, I; Kuritzkes, DR; Paredes, R; Tuomala, RE1
Anceschi, MM; Ascenzi, P; Ivanovic, J; Mattia, E; Narciso, P; Nicastri, E; Notari, S; Pisani, G; Pucillo, LP; Signore, F; Tempestilli, M; Vallone, C1
Ellis, GM; Frenkel, LM; Hitti, J; Huang, S1
Nsanzabana, C; Rosenthal, PJ1
Boer, K; Godfried, MH; Nellen, J; Scherpbier, H; van Hoog, S1
Bastos, FI; Bethel, J; Bryson, YJ; Camarca, M; Ceriotto, M; Dickover, R; Fonseca, R; Gray, G; Grinsztejn, B; Joao, EC; Kreitchmann, R; Machado, D; Mirochnick, M; Mofenson, LM; Moreira, RI; Morgado, MG; Moye, J; Mussi-Pinhata, MM; Nielsen-Saines, K; Pilotto, JH; Pinto, J; Santos, B; Siberry, G; Theron, G; Veloso, VG; Watts, DH; Xu, J1
Akoth, B; Angira, F; Masaba, R; Mills, LA; Minniear, TD; Ndivo, R; Oyaro, B; Peters, PJ; Polle, N; Thomas, TK; Zeh, C1

Reviews

4 review(s) available for nevirapine and nelfinavir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antiretroviral chemotherapy.
    Current clinical topics in infectious diseases, 1998, Volume: 18

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine

1998
Antiretrovirals.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cyclopropanes; Delavirdine; Didanosine; Dideoxynucleosides; Female; Furans; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Oxazines; Pregnancy; Pregnancy Complications, Infectious; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Stavudine; Sulfonamides; Zalcitabine; Zidovudine

1999
Efficacy of highly active antiretroviral therapy in HIV-1 infected children.
    The Lancet. Infectious diseases, 2002, Volume: 2, Issue:2

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Indinavir; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir

2002

Trials

26 trial(s) available for nevirapine and nelfinavir

ArticleYear
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:6

    Topics: Adult; Drug Resistance; HIV Protease; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Indinavir; Male; Middle Aged; Nelfinavir; Nevirapine; Polypharmacy; Prognosis; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir

1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:6

    Topics: Adult; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Nelfinavir; Nevirapine; Phenotype; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Salvage Therapy; Saquinavir

1999
dNN study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions.
    Antiviral therapy, 1998, Volume: 3 Suppl 4

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; Humans; Nelfinavir; Nevirapine; Research Design; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine

1998
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:5

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Indinavir; Injections, Subcutaneous; Interleukin-2; Lamivudine; Lymphocyte Count; Male; Nelfinavir; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Zalcitabine; Zidovudine

2000
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clin
    AIDS research and human retroviruses, 2000, Aug-10, Volume: 16, Issue:12

    Topics: Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Ethnicity; Female; HIV Infections; Humans; Infant; Male; Nelfinavir; Nevirapine; Puerto Rico; Racial Groups; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Stavudine; Time Factors; United States; Viral Load

2000
Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.
    AIDS research and human retroviruses, 2001, Jan-20, Volume: 17, Issue:2

    Topics: Adult; Aged; Anti-HIV Agents; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Prospective Studies; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Treatment Failure; Viral Load

2001
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
    The Journal of infectious diseases, 2001, Jun-15, Volume: 183, Issue:12

    Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cohort Studies; Drug Resistance, Microbial; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Lamivudine; Male; Mutation; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Stavudine; Treatment Failure; Viral Load

2001
Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:6

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; Humans; Male; Nelfinavir; Nevirapine; Oxazines; Prospective Studies; Salvage Therapy

2001
The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients: a prospective, open-label, controlled, randomized study.
    Journal of acquired immune deficiency syndromes (1999), 2001, Jun-01, Volume: 27, Issue:2

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Nelfinavir; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral

2001
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.
    AIDS (London, England), 2002, Jan-04, Volume: 16, Issue:1

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Administration Schedule; Female; HIV Infections; HIV-1; Humans; Indinavir; Male; Middle Aged; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load

2002
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Apr-01, Volume: 34, Issue:7

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Stavudine

2002
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
    Pediatrics, 2002, Volume: 109, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Drug Administration Schedule; Humans; Lamivudine; Nelfinavir; Nevirapine; Patient Compliance; Ritonavir; RNA, Viral; Stavudine; Treatment Outcome; Viral Load

2002
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Antiviral therapy, 2002, Volume: 7, Issue:2

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Treatment Outcome; Zidovudine

2002
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
    The Journal of infectious diseases, 2003, Feb-15, Volume: 187, Issue:4

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Argentina; Cohort Studies; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Middle Aged; Mutation; Nelfinavir; Nevirapine; Phenotype; Reverse Transcriptase Inhibitors; Spain; Treatment Failure; Zidovudine

2003
Nelfinavir pharmacokinetics in stable human immunodeficiency virus-positive children: Pediatric AIDS Clinical Trials Group Protocol 377.
    Pediatrics, 2003, Volume: 112, Issue:3 Pt 1

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antiretroviral Therapy, Highly Active; Biological Availability; Body Weight; Child; Child, Preschool; Dosage Forms; Drug Administration Schedule; HIV Protease Inhibitors; HIV-1; Humans; Infant; Nelfinavir; Nevirapine

2003
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
    AIDS (London, England), 2003, Sep-26, Volume: 17, Issue:14

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lactates; Male; Middle Aged; Nelfinavir; Nervous System Diseases; Nevirapine; Ritonavir; RNA, Viral; Saquinavir; Stavudine; Treatment Outcome

2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:11

    Topics: Adult; Anti-HIV Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Energy Metabolism; Female; HIV Infections; HIV Protease Inhibitors; Humans; Insulin; Male; Middle Aged; Nelfinavir; Nevirapine; Triglycerides

2003
A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
    Antiviral therapy, 2003, Volume: 8, Issue:6

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Saquinavir

2003
Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
    Antiviral therapy, 2004, Volume: 9, Issue:2

    Topics: Adult; Aged; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lamivudine; Lymphocyte Activation; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Zidovudine

2004
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.
    Journal of acquired immune deficiency syndromes (1999), 2004, Jul-01, Volume: 36, Issue:3

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Newborn; Liver Failure, Acute; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Safety; Stevens-Johnson Syndrome

2004
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Didanosine; Female; HIV Infections; HIV-1; Humans; Infant; Male; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Outcome

2005
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
    HIV medicine, 2006, Volume: 7, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine

2006
Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions.
    Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:2

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Area Under Curve; Benzoxazines; CD4 Lymphocyte Count; Chromatography, Liquid; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Female; Half-Life; HIV Infections; HIV Protease Inhibitors; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Nelfinavir; Nevirapine; Ovulation Inhibition; Oxazines; Progesterone; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors

2007
A virological benefit from an induction/maintenance strategy: the Forte trial.
    Antiviral therapy, 2007, Volume: 12, Issue:1

    Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Patient Compliance; Remission Induction; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Time Factors; Treatment Failure; United Kingdom; Viral Load

2007
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.
    Contraception, 2008, Volume: 77, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Nelfinavir; Nevirapine; Ovulation Inhibition; RNA, Viral; Safety; Viral Load

2008
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
    The New England journal of medicine, 2012, Jun-21, Volume: 366, Issue:25

    Topics: Anti-Retroviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Infant Formula; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Nelfinavir; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2012

Other Studies

58 other study(ies) available for nevirapine and nelfinavir

ArticleYear
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
More new drugs for HIV and associated infections.
    The Medical letter on drugs and therapeutics, 1997, Feb-14, Volume: 39, Issue:994

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; HIV Infections; Humans; Isoquinolines; Nelfinavir; Nevirapine; Organophosphonates; Organophosphorus Compounds; Protease Inhibitors; Pyridines; Ritonavir; Sulfonic Acids

1997
Drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 1997, Dec-12, Volume: 39, Issue:1015

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine

1997
Confusion of nelfinavir and nevirapine.
    The New England journal of medicine, 1998, Feb-05, Volume: 338, Issue:6

    Topics: Anti-HIV Agents; Drug Labeling; Female; HIV Infections; Humans; Medication Errors; Nelfinavir; Nevirapine; Pharmacy

1998
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine.
    AIDS (London, England), 1998, Jul-09, Volume: 12, Issue:10

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors

1998
Lack of pharmacokinetic interaction between nelfinavir and nevirapine.
    AIDS (London, England), 1998, Jul-09, Volume: 12, Issue:10

    Topics: Anti-HIV Agents; Cytochrome P-450 Enzyme System; Drug Interactions; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors

1998
HIV-1 peripheral neuropathy and combination antiretroviral therapy.
    Lancet (London, England), 1998, Dec-12, Volume: 352, Issue:9144

    Topics: Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Nelfinavir; Nevirapine; Peripheral Nervous System Diseases; Saquinavir; Zidovudine

1998
Nelfinavir and nevirapine interaction?
    AIDS (London, England), 1998, Dec-03, Volume: 12, Issue:17

    Topics: Anti-HIV Agents; Drug Interactions; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors

1998
Potential confusion with antiretroviral drugs.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24

    Topics: Anti-HIV Agents; Humans; Nelfinavir; Nevirapine; Terminology as Topic

1998
Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Alkaloids; Anti-HIV Agents; Anti-Infective Agents; Benzylisoquinolines; Cell Line; Drug Synergism; Fluoroquinolones; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; NF-kappa B; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine

1999
Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual.
    AIDS (London, England), 1999, Oct-22, Volume: 13, Issue:15

    Topics: Administration, Oral; Anti-HIV Agents; Drug Therapy, Combination; HIV Envelope Protein gp41; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Nelfinavir; Nevirapine; Peptides; Reverse Transcriptase Inhibitors; Saquinavir

1999
Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infection.
    AIDS research and human retroviruses, 2000, Feb-10, Volume: 16, Issue:3

    Topics: Anti-HIV Agents; Capsid; Capsid Proteins; Cell Division; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Freezing; gag Gene Products, Human Immunodeficiency Virus; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Protease Inhibitors; HIV-1; Humans; Microscopy, Electron; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; T-Lymphocytes; Time Factors; Viral Proteins

2000
Are nelfinavir-containing regimens effective as second-line triple therapy?
    AIDS (London, England), 2000, Jan-07, Volume: 14, Issue:1

    Topics: Dideoxynucleosides; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Stavudine

2000
The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Infant; Lamivudine; Male; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Treatment Outcome; Zidovudine

2000
Pharmacokinetics of nelfinavir and nevirapine in a patient with end-stage renal failure on continuous ambulatory peritoneal dialysis.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:5

    Topics: Adult; Anti-HIV Agents; Female; HIV Infections; HIV-1; Humans; Kidney Failure, Chronic; Nelfinavir; Nevirapine; Peritoneal Dialysis, Continuous Ambulatory; Reverse Transcriptase Inhibitors

2000
Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Apr-01, Volume: 32, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chronic Disease; Didanosine; Female; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Parvoviridae Infections; Parvovirus B19, Human; Reverse Transcriptase Inhibitors; Treatment Outcome

2001
Data on nevirapine combinations released.
    AIDS patient care and STDs, 1998, Volume: 12, Issue:4

    Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Nevirapine; Viral Load

1998
Viracept combination studies.
    AIDS patient care and STDs, 1998, Volume: 12, Issue:6

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Humans; Indinavir; Nelfinavir; Nevirapine; Oxazines; Ritonavir; Saquinavir; Stavudine

1998
Salvage therapy studies.
    Project Inform perspective, 1998, Issue:25

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Salvage Therapy; Saquinavir; Viral Load

1998
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
    Therapeutic drug monitoring, 2001, Volume: 23, Issue:4

    Topics: Alkynes; Benzoxazines; Carbamates; Chromatography, Liquid; Cyclopropanes; Delavirdine; Drug Monitoring; Furans; HIV Protease Inhibitors; Humans; Indinavir; Mass Spectrometry; Nelfinavir; Nevirapine; Oxazines; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides

2001
High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid e
    Journal of chromatography. B, Biomedical sciences and applications, 2001, Jul-15, Volume: 758, Issue:2

    Topics: Calibration; Carbamates; Chromatography, High Pressure Liquid; Furans; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Nevirapine; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides

2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
    Archives of internal medicine, 2001, Sep-10, Volume: 161, Issue:16

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Cohort Studies; Drug Administration Schedule; Female; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Male; Middle Aged; Nelfinavir; Nevirapine; Odds Ratio; Patient Compliance; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Saquinavir; Surveys and Questionnaires

2001
Drugs for HIV infection.
    The Medical letter on drugs and therapeutics, 2001, Nov-26, Volume: 43, Issue:1119

    Topics: Alkynes; Benzoxazines; Cyclopropanes; Delavirdine; Didanosine; Dose-Response Relationship, Drug; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine; Zidovudine

2001
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Therapeutic drug monitoring, 2002, Volume: 24, Issue:3

    Topics: Alkynes; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Monitoring; Furans; HIV Infections; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sulfonamides

2002
Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Therapeutic drug monitoring, 2003, Volume: 25, Issue:3

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Chromatography, High Pressure Liquid; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Nelfinavir; Nevirapine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir

2003
Mitochondrial effects of antiretroviral therapies in asymptomatic patients.
    Antiviral therapy, 2004, Volume: 9, Issue:1

    Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Base Sequence; Cross-Sectional Studies; Didanosine; DNA Primers; DNA, Mitochondrial; Female; HIV Infections; Humans; Lamivudine; Male; Mitochondria; Nelfinavir; Nevirapine; Polymerase Chain Reaction; Stavudine

2004
Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adults.
    Journal of acquired immune deficiency syndromes (1999), 2004, Apr-01, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Anti-HIV Agents; Area Under Curve; CD4 Lymphocyte Count; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Nevirapine; Stavudine; Viral Load

2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression.
    AIDS (London, England), 2004, Sep-03, Volume: 18, Issue:13

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Nelfinavir; Nevirapine; Oxazines; Prospective Studies; Viral Load

2004
Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.
    American journal of obstetrics and gynecology, 2004, Volume: 191, Issue:3

    Topics: Abnormalities, Drug-Induced; Anti-Retroviral Agents; Female; Gestational Age; Humans; Lamivudine; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Outcome; Prospective Studies; Risk Factors; Stavudine; Zidovudine

2004
[Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Nederlands tijdschrift voor geneeskunde, 2004, Oct-09, Volume: 148, Issue:41

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; Fetus; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nelfinavir; Netherlands; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Treatment Outcome; Viral Load

2004
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Hepatitis; HIV Infections; Humans; Indinavir; Liver Function Tests; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine

2005
Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevi
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:2

    Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Calibration; Carbamates; Chromatography, Liquid; Cyclopropanes; Drug Stability; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oligopeptides; Oxazines; Pyridines; Pyrimidinones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Specimen Handling; Spectrophotometry, Ultraviolet; Sulfonamides

2005
Nelfinavir and nevirapine side effects during pregnancy.
    AIDS (London, England), 2005, May-20, Volume: 19, Issue:8

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperglycemia; Nausea; Nelfinavir; Netherlands; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors

2005
In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:4

    Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Combinations; Drug Interactions; HIV-1; Humans; Lamivudine; Least-Squares Analysis; Models, Theoretical; Nelfinavir; Nevirapine; Phenotype; Stavudine; Thymidine Monophosphate; Virus Replication; Zidovudine

2005
TDM: therapeutic drug measuring or therapeutic drug monitoring?
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:4

    Topics: Anti-Retroviral Agents; Carbamazepine; Drug Interactions; Drug Monitoring; Drug Resistance, Viral; HIV Infections; Humans; Indinavir; Nelfinavir; Nevirapine; Patient Compliance; Quality Control; Surveys and Questionnaires

2005
HIV antiretroviral agents inhibit protein synthesis and decrease ribosomal protein S6 and 4EBP1 phosphorylation in C2C12 myocytes.
    AIDS research and human retroviruses, 2005, Volume: 21, Issue:10

    Topics: Animals; Anti-HIV Agents; Cell Line; Mice; Muscle Cells; Nelfinavir; Nevirapine; Phosphorylation; Protein Synthesis Inhibitors; Ribosomal Protein S6; Zidovudine

2005
Effect of widely used combinations of antiretroviral therapy on liver CYP3A4 activity in HIV-infected patients.
    British journal of clinical pharmacology, 2006, Volume: 62, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Cohort Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Female; HIV Infections; Humans; Indinavir; Liver; Male; Nelfinavir; Nevirapine; Ritonavir; Sex Factors

2006
An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Apr-01, Volume: 848, Issue:2

    Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oligopeptides; Pyridines; Pyrimidinones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Spectrophotometry, Ultraviolet; Sulfonamides

2007
High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Journal of pharmaceutical and biomedical analysis, 2007, Mar-12, Volume: 43, Issue:4

    Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Drug Stability; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Molecular Structure; Nelfinavir; Nevirapine; Oligopeptides; Oxazines; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfonamides; Time Factors

2007
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
    Journal of acquired immune deficiency syndromes (1999), 2007, May-01, Volume: 45, Issue:1

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black People; Cholesterol; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Fasting; Female; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Multivariate Analysis; Nelfinavir; Nevirapine; Organophosphonates; Ritonavir; Stavudine; Tenofovir; Triglycerides; United States; White People

2007
Uncomplicated outcome after an accidental overdose of nevirapine in a newborn.
    European journal of pediatrics, 2008, Volume: 167, Issue:6

    Topics: Anti-HIV Agents; Drug Overdose; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Medication Errors; Nelfinavir; Nevirapine

2008
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
    The Journal of infectious diseases, 2007, Dec-01, Volume: 196, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Female; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Salvage Therapy

2007
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.
    Journal of neurovirology, 2008, Volume: 14, Issue:1

    Topics: Adenine; Adult; AIDS Dementia Complex; Alkynes; Anti-HIV Agents; Anticonvulsants; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Didanosine; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Nevirapine; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Seizures; Stavudine; Tenofovir; Viral Load; Virus Replication; Zidovudine

2008
Possible antiretroviral therapy-warfarin drug interaction.
    Pharmacotherapy, 2008, Volume: 28, Issue:7

    Topics: Adult; Anticoagulants; Antiretroviral Therapy, Highly Active; Drug Combinations; Drug Interactions; Humans; Lopinavir; Middle Aged; Nelfinavir; Nevirapine; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Warfarin

2008
Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:5

    Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Lopinavir; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Viral Load; Young Adult

2008
Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Clinical chemistry, 2009, Volume: 55, Issue:1

    Topics: Alkynes; Atazanavir Sulfate; Benzoxazines; Carbamates; Chromatography, High Pressure Liquid; Cyclopropanes; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Nevirapine; Oligopeptides; Pyridines; Pyrimidinones; Pyrones; Reproducibility of Results; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sensitivity and Specificity; Solid Phase Extraction; Sulfonamides

2009
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
    AIDS (London, England), 2010, Jan-02, Volume: 24, Issue:1

    Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nelfinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Zidovudine

2010
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women.
    Current HIV research, 2009, Volume: 7, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apgar Score; Atazanavir Sulfate; Birth Weight; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Lopinavir; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Oligopeptides; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Pyrimidinones

2009
Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.
    Journal of acquired immune deficiency syndromes (1999), 2011, Nov-01, Volume: 58, Issue:3

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Microbial Sensitivity Tests; Nelfinavir; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Selection, Genetic

2011
In vitro activity of antiretroviral drugs against Plasmodium falciparum.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Alkynes; Animals; Anti-Retroviral Agents; Antimalarials; Benzoxazines; Carbamates; Cyclopropanes; Darunavir; Furans; Lopinavir; Nelfinavir; Nevirapine; Plasmodium falciparum; Pyridines; Pyrones; Ritonavir; Saquinavir; Sulfonamides

2011
Transplacental passage of nevirapine, nelfinavir and lopinavir.
    The Netherlands journal of medicine, 2012, Volume: 70, Issue:2

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Female; Fetal Blood; HIV Infections; Humans; Lopinavir; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Pregnancy

2012
Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:11

    Topics: Adult; Aging, Premature; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Nelfinavir; Nevirapine; Pregnancy

2012
Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure s
    National Toxicology Program technical report series, 2013, Issue:569

    Topics: Administration, Oral; Animals; Anti-Retroviral Agents; DNA; Drug Therapy, Combination; Escherichia coli; Female; Lamivudine; Longevity; Male; Maternal Exposure; Mice; Mice, Inbred Strains; Nelfinavir; Nevirapine; Pregnancy; Prenatal Exposure Delayed Effects; Salmonella typhimurium; Skin Neoplasms; Zidovudine

2013